Blood Transfusion Among Patients With Pelvic Fracture in China

Status Recruiting

Clinical Trial Summary

According to the patient's blood management concept, this study intends to collect basic information, surgical data, blood transfusion related data and patient prognosis data of patients with pelvic fractures, and to construct a predictive model of intraoperative blood transfusion in patients with pelvic fractures by multiple linear regression analysis. To guide physicians use blood accurately during surgery. Prompt doctors to reduce blood transfusion dose and improve patient prognosis by stopping bleeding and blood recovery before surgery.

Clinical Trial Description

2.1 Research Objectives: This study aims to construct a blood transfusion model for pelvic fractures, to guide the rational use of blood during surgery, and to improve the prognosis of patients.

2.2 Research content: 2.2.1 Collect basic data, surgical data, blood transfusion related data and patient prognosis related data of patients with pelvic fractures.

2.2.2 Gradually incorporate and exclude data from multiple linear regression models.

2.2.3 Verify the specificity and sensitivity of the intraoperative blood transfusion prediction model.

2.2.4 Create a visualization window to guide clinical blood. 2.2.5 Put into clinical trial and feedback, and continue to verify 2.3 Key issues to be resolved 2.3.1 The factors related to intraoperative blood transfusion in patients with pelvic fractures (such as blood oxygenation, blood loss, HB value, intraoperative autologous blood recovery, blood pressure, heart rate, etc.) were initially screened by univariate analysis.

2.3.2 Reasonably standardize the objective and subjective indicators of different units and different institutions.

2.4 Expected research results Intraoperative blood transfusion prediction model and window for patients with pelvic fractures.

2.5 Assessment indicators Published 1-2 papers. Create a visual applet and put it into trial. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03855644
Study type	Observational [Patient Registry]
Source	The Third Xiangya Hospital of Central South University
Contact	Rong Gui, Ph.D
Phone	13975199279
Email	aguirong@163.com
Status	Recruiting
Phase
Start date	April 5, 2019
Completion date	September 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05606042` - Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Evaluation
Not yet recruiting	`NCT06054165` - Impact of a Clinical Pathway for Pelvic Fragility Fractures	N/A
Recruiting	`NCT04744350` - Conservative or Operative Therapy in Patients With a Fragility Fracture of the Pelvis	N/A
Enrolling by invitation	`NCT03977168` - A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring
Completed	`NCT03475771` - Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture Surgery
Active, not recruiting	`NCT05354531` - Outcome of the Anterior Subcutaneous Internal Fixator (INFIX) for Pelvic Ring Disruptions	N/A
Completed	`NCT06388915` - A Retrospective Cohort Study of 15 Cases of Pelvic Fractures Complicated by Morel-Lavallee Lesion
Active, not recruiting	`NCT05836727` - Use of Laparoscopy in the Treatment of Pelvic Ring Ruptures
Recruiting	`NCT04182776` - Fragility Fractures of the Pelvis (FFP)
Not yet recruiting	`NCT03944174` - Single Trans-sacral Screw Versus Two Iliosacral Screws
Not yet recruiting	`NCT05448911` - The Role of Intraoperative Navigation-assisted Channel Screw Technique in the Treatment of Pelvic Fractures	N/A
Completed	`NCT02855060` - Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis	N/A
Recruiting	`NCT05367505` - Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis	N/A
Completed	`NCT04217499` - Pelvic Ring Fractures: New Analysis Method and Treatment Decision Algorithm
Terminated	`NCT00594906` - Use of Teriparatide to Accelerate Fracture Healing	N/A
Completed	`NCT04303442` - Corona Mortis in Patients Undergoing TEP for Inguinal Hernia
Enrolling by invitation	`NCT05712850` - Clinical Outcome and Fusion Results Using the SiJoin® Transfixing Sacroiliac Fusion Device
Recruiting	`NCT04937868` - Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
Withdrawn	`NCT04764864` - Pelvic Fractures in Polytraumatized Patients With Hemodynamic Instability: Angioembolization vs Preperitoneal Packing	N/A
Recruiting	`NCT04615104` - Pelvic and Acetabular Fracture: A Prospective Observational Study

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Blood Transfusion Among Patients With Pelvic Fracture in China — PBM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms